Cannell & Co. Quanterix Corp Transaction History

Cannell & Co.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$37.54 - $57.51 $590,241 - $904,229	-15,723 Reduced 14.77%	90,745 $3.85 Million
Q3 2021 Nov 10, 2021	SELL	$45.91 - $59.67 $32,596 - $42,365	-710 Reduced 0.66%	106,468 $5.3 Million
Q2 2021 Aug 09, 2021	SELL	$43.3 - $67.17 $6,495 - $10,075	-150 Reduced 0.14%	107,178 $6.29 Million
Q1 2021 May 07, 2021	BUY	$44.11 - $90.64 $3.09 Million - $6.34 Million	70,000 Added 187.53%	107,328 $6.28 Million
Q2 2020 Aug 07, 2020	BUY	$19.21 - $28.53 $717,070 - $1.06 Million	37,328 New	37,328 $1.02 Million

155

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $436M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

Stay updated on Cannell & Co. with notifications on news.